Testing effectiveness (Phase 2)Ended earlyNCT02689219
What this trial is testing
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Who this might be right for
Germ Cell TumorsTestis CancerTesticular Cancer+2 more
Nabil Adra 18
Showing 6 of 6 results